← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Murty Pharmaceuticals, Inc.
Lexington, KY
$8,102,570
Total funding
9
Grants
Funding over time
peak $1.3M · FY2008–23$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$8,102,570 · 9
By mechanism
N01$7,749,138 · 6
N43$198,432 · 2
N44$155,000 · 1
Investigators at Murty Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
TAS::75 0893::TAS DEVELOPMENT AND MANUFACTURE OF PHARMACEUTICAL PRODUCTS/ADDICT$1,317,004
N01 · FY2011 · DA
OTHER FUNCTIONS: Development and Manufacture of Pharmaceutical Products for Addic$856,983
N01 · FY2015 · DA
Development & Manufacture of Pharmaceutical Products for Addiction Treatment$836,227
N01 · FY2008 · DA
Development & Manufacture of Pharmaceutical Products for Addiction Treatment$816,752
N01 · FY2010 · DA
Development & Manufacture of Pharmaceutical Products for Addiction Treatment$784,485
N01 · FY2009 · DA
IGF::OT::IGF Development & Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorcer. NIDA Ref. No. N01DA-16-8926; POP: 09/18/2016 - 09/17/2021.$697,612
N01 · FY2017 · DA
Pharmaceutical Formulation of Lead Drug Candidates$334,667
N01 · FY2012 · AG
PHARMACEUTICAL PREPARATIONS FOR ADDICTION TREATMENT$332,588
N01 · FY2000 · DA
IGF::OT::IGF Development & Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorder. NIDA Ref. No. N01DA-16-8926; POP: 09/18/2016 - 09/17/2021.$308,187
N01 · FY2018 · DA
PHARMACEUTICAL PREPARATIONS FOR ADDICTION TREATMENT$300,000
N01 · FY2000 · DA
OTHER FUNCTIONS: Development and Manufacture of Pharmaceutical Products for Addic$286,466
N01 · FY2014 · DA
MANUFACTURE OF MORPHINE SULFATE PELLETS; TASK ORDER 03, FY23$245,582
N01 · FY2023 · DA
IGF::OT::IGF Development & Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorcer. NIDA Ref. No. N01DA-16-8926; POP: 09/18/2016 - 09/17/2021.$155,703
N01 · FY2016 · DA
PREPARATION OF STANDARDIZED NICOTINE AND CIGARETTES$155,000
N44 · FY2000 · DA
OTHER FUNCTIONS: Development and Manufacture of Pharmaceutical Products for Addic$100,000
N01 · FY2013 · DA
TRANSDERMAL DELIVERY OF TETRAHYDRO-CANNABINOL$99,683
N43 · FY2000 · DA
DEVELOPMENT OF PLACEBO MARIJUANA CIGARETTES$98,749
N43 · FY2000 · DA
DEVELOPMENT&MANUFACTURE OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF SUBSTANCE ABUSE DISORDERS. NIDA REF. NO. N01DA-16-8926; POP: 09/18/2016 - 09/1$97,575
N01 · FY2020 · DA
DEVELOPMENT & MANUFACTURE OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF SUBSTANCE ABUSE DISORDERS. NIDA REF. NO. N01DA-16-8926; POP: 09/18/2016 - 09/17/2021.$93,608
N01 · FY2019 · DA
FY23. DRUG PRODUCT STABILITY STUDIES. PERIOD OF PERFORMANCE: SEPTEMBER 13, 2023 - SEPTEMBER 12, 2024$90,784
N01 · FY2023 · DA